
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $105.4M | $125.5M | $165.6M | $186.3M | $171.2M | |
Selling, General & Admin | $28.9M | $41.8M | $58.8M | $73.3M | $102M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $134.3M | $166.2M | $223.8M | $259.7M | $273.2M | |
Operating Income | -$134.3M | -$166.2M | -$223.8M | -$259.7M | -$273.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$139.7M | -$169.1M | -$221.9M | -$245.6M | -$258.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$139.7M | -$169.1M | -$221.9M | -$245.6M | -$258.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$139.7M | -$169.1M | -$221.9M | -$245.6M | -$258.7M | |
Basic EPS (Cont. Ops) | -$2.52 | -$2.67 | -$3.26 | -$2.92 | -$2.73 | |
Diluted EPS (Cont. Ops) | -$2.52 | -$2.67 | -$3.26 | -$2.92 | -$2.73 | |
Weighted Average Basic Share | $55.4M | $63.2M | $68.1M | $84M | $94.8M | |
Weighted Average Diluted Share | $55.4M | $63.2M | $68.1M | $84M | $94.8M | |
EBITDA | -$125.9M | -$157.8M | -$213.7M | -$236.6M | -$247.5M | |
EBIT | -$132.2M | -$163.2M | -$220M | -$243.7M | -$256.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$134.3M | -$166.2M | -$223.8M | -$259.7M | -$273.2M | |
Operating Income (Adjusted) | -$132.2M | -$163.2M | -$220M | -$243.7M | -$256.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $28.3M | $30.8M | $46.4M | $45.2M | $35.9M | |
Selling, General & Admin | $10.9M | $11.8M | $15.8M | $22.1M | $28.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $38.7M | $42.6M | $62.2M | $67.4M | $64.4M | |
Operating Income | -$38.7M | -$42.6M | -$62.2M | -$67.4M | -$64.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Basic EPS (Cont. Ops) | -$0.65 | -$0.67 | -$0.73 | -$0.66 | -$0.56 | |
Diluted EPS (Cont. Ops) | -$0.65 | -$0.67 | -$0.73 | -$0.66 | -$0.56 | |
Weighted Average Basic Share | $61.6M | $64.5M | $79.5M | $93.5M | $110.1M | |
Weighted Average Diluted Share | $61.6M | $64.5M | $79.5M | $93.5M | $110.1M | |
EBITDA | -$37.1M | -$40.6M | -$56.2M | -$59.3M | -$57.9M | |
EBIT | -$37.8M | -$41.9M | -$57.9M | -$61.6M | -$60.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$38.7M | -$42.6M | -$62.2M | -$67.4M | -$64.4M | |
Operating Income (Adjusted) | -$37.8M | -$41.9M | -$57.9M | -$61.6M | -$60.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $116.8M | $128M | $181.1M | $185.2M | $162M | |
Selling, General & Admin | $32.6M | $42.6M | $62.8M | $79.6M | $108.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $148.9M | $170.1M | $243.5M | $264.8M | $270.2M | |
Operating Income | -$148.9M | -$170.1M | -$243.5M | -$264.8M | -$270.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$155.2M | -$171.9M | -$237.2M | -$249.3M | -$258M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$155.2M | -$171.9M | -$237.2M | -$249.3M | -$258M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$155.2M | -$171.9M | -$237.2M | -$249.3M | -$258M | |
Basic EPS (Cont. Ops) | -$2.72 | -$2.70 | -$3.32 | -$2.87 | -$2.63 | |
Diluted EPS (Cont. Ops) | -$2.72 | -$2.70 | -$3.32 | -$2.87 | -$2.63 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$140M | -$161.3M | -$229.2M | -$239.8M | -$246M | |
EBIT | -$146.8M | -$167.3M | -$235.9M | -$247.4M | -$256.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$148.9M | -$170.1M | -$243.5M | -$264.8M | -$270.2M | |
Operating Income (Adjusted) | -$146.8M | -$167.3M | -$235.9M | -$247.4M | -$256.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $28.3M | $30.8M | $46.4M | $45.2M | $35.9M | |
Selling, General & Admin | $10.9M | $11.8M | $15.8M | $22.1M | $28.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $38.7M | $42.6M | $62.2M | $67.4M | $64.4M | |
Operating Income | -$38.7M | -$42.6M | -$62.2M | -$67.4M | -$64.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Basic EPS (Cont. Ops) | -$0.65 | -$0.67 | -$0.73 | -$0.66 | -$0.56 | |
Diluted EPS (Cont. Ops) | -$0.65 | -$0.67 | -$0.73 | -$0.66 | -$0.56 | |
Weighted Average Basic Share | $61.6M | $64.5M | $79.5M | $93.5M | $110.1M | |
Weighted Average Diluted Share | $61.6M | $64.5M | $79.5M | $93.5M | $110.1M | |
EBITDA | -$37.1M | -$40.6M | -$56.2M | -$59.3M | -$57.9M | |
EBIT | -$37.8M | -$41.9M | -$57.9M | -$61.6M | -$60.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$38.7M | -$42.6M | -$62.2M | -$67.4M | -$64.4M | |
Operating Income (Adjusted) | -$37.8M | -$41.9M | -$57.9M | -$61.6M | -$60.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $297.1M | $232.7M | $140.5M | $55.9M | $163.6M | |
Short Term Investments | $185.6M | $156M | $215.9M | $317.3M | $208.7M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $4.6M | $3.3M | $7.7M | $5M | $5.8M | |
Total Current Assets | $487.3M | $392.1M | $364.1M | $378.2M | $378.2M | |
Property Plant And Equipment | $70.6M | $72.3M | $77.6M | $87.6M | $83.3M | |
Long-Term Investments | -- | -- | $43.3M | $34.3M | -- | |
Goodwill | $30.8M | $30.8M | $39.2M | $39.2M | $39.2M | |
Other Intangibles | -- | -- | $25.7M | $25.2M | $25.2M | |
Other Long-Term Assets | $1.6M | $1.3M | $1.3M | $1.4M | $1.4M | |
Total Assets | $590.8M | $497M | $551.8M | $566.3M | $527.7M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $20M | $14.5M | $26.1M | $22.7M | $25.9M | |
Current Portion Of Long-Term Debt | $4.9M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.3M | $2.6M | $2.5M | $2.7M | $2.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $32.6M | $22.2M | $39.2M | $48.5M | $40.7M | |
Long-Term Debt | $35.1M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $87.3M | $42.3M | $62.1M | $73.8M | $64.5M | |
Common Stock | $610K | $645K | $791K | $903K | $1.1M | |
Other Common Equity Adj | -$42K | -$161K | -$357K | $319K | $66K | |
Common Equity | $503.5M | $454.7M | $489.7M | $492.6M | $463.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $503.5M | $454.7M | $489.7M | $492.6M | $463.2M | |
Total Liabilities and Equity | $590.8M | $497M | $551.8M | $566.3M | $527.7M | |
Cash and Short Terms | $482.7M | $388.7M | $356.4M | $373.2M | $372.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $252.5M | $130.6M | $64.6M | $35.3M | $49.8M | |
Short Term Investments | $213.8M | $216M | $266.5M | $295M | $268.4M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.5M | $7.3M | $6.9M | $14.8M | $6.3M | |
Total Current Assets | $471.8M | $353.8M | $338M | $345.2M | $324.5M | |
Property Plant And Equipment | $71.9M | $73.7M | $81.1M | $88.1M | $80.4M | |
Long-Term Investments | -- | -- | $29M | -- | -- | |
Goodwill | $30.8M | $30.8M | $39.2M | $39.2M | $39.2M | |
Other Intangibles | -- | -- | $25.7M | $25.2M | $25.2M | |
Other Long-Term Assets | $1.5M | $1.3M | $1.3M | $1.4M | $1.4M | |
Total Assets | $576.5M | $460.2M | $514.8M | $499.4M | $471.1M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $26.4M | $18M | $23.8M | $25.9M | $25.4M | |
Current Portion Of Long-Term Debt | $5M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.3M | $2.5M | $2.6M | $2.9M | $2.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $40.5M | $22.6M | $31.2M | $33M | $35.3M | |
Long-Term Debt | $35.5M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $96.5M | $42.5M | $55.9M | $57.9M | $58.9M | |
Common Stock | $619K | $645K | $804K | $906K | $1.1M | |
Other Common Equity Adj | -$75K | -$629K | -$90K | -$135K | -$27K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $480M | $417.6M | $458.9M | $441.5M | $412.1M | |
Total Liabilities and Equity | $576.5M | $460.2M | $514.8M | $499.4M | $471.1M | |
Cash and Short Terms | $466.4M | $346.6M | $331.1M | $330.3M | $318.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$139.7M | -$169.1M | -$221.9M | -$245.6M | -$258.7M | |
Depreciation & Amoritzation | $6.3M | $5.4M | $6.3M | $7.1M | $9.4M | |
Stock-Based Compensation | $18.6M | $29.2M | $31M | $39.4M | $43.9M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$74.6M | -$121.2M | -$178.1M | -$194.9M | -$209.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | $42.7M | -- | -- | |
Cash From Investing | -$96.6M | $18.9M | -$69.3M | -$98.1M | $131.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$72K | -- | -$47K | -- | -- | |
Other Financing Activities | -$851K | -- | -- | -- | -- | |
Cash From Financing | $283M | $37.7M | $155.3M | $208.4M | $185.7M | |
Beginning Cash (CF) | $186.9M | $298.7M | $234M | $141.9M | $57.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $111.8M | -$64.6M | -$92.2M | -$84.6M | $107.7M | |
Ending Cash (CF) | $298.7M | $234M | $141.9M | $57.3M | $165M | |
Levered Free Cash Flow | -$103.7M | -$128.9M | -$186.8M | -$211.4M | -$215.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Depreciation & Amoritzation | $674K | $1.3M | $1.7M | $2.3M | $3M | |
Stock-Based Compensation | $7.9M | $6.3M | $8.9M | $10.3M | $10.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$24.3M | -$39.2M | -$57.6M | -$56.9M | -$55.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$29.2M | -$63M | -$36.7M | $35M | -$58M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $8.8M | $76K | $18.3M | $1.2M | -- | |
Beginning Cash (CF) | $298.7M | $234M | $141.9M | $57.3M | $165M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$44.7M | -$102.1M | -$75.9M | -$20.6M | -$113.8M | |
Ending Cash (CF) | $254M | $131.9M | $65.9M | $36.6M | $51.2M | |
Levered Free Cash Flow | -$24.6M | -$41.2M | -$60.6M | -$58.9M | -$56.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$155.2M | -$171.9M | -$237.2M | -$249.3M | -$258M | |
Depreciation & Amoritzation | $6.8M | $6M | $6.6M | $7.7M | $10.1M | |
Stock-Based Compensation | $22.5M | $27.6M | $33.7M | $40.7M | $44M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$76.7M | -$136.1M | -$196.5M | -$194.2M | -$208.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$153.3M | -$15M | -$43.1M | -$26.3M | $38.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $291.9M | $29M | $173.6M | $191.2M | $184.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $62M | -$122.1M | -$66M | -$29.3M | $14.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$100.2M | -$145.4M | -$206.2M | -$209.7M | -$212.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$40.2M | -$43M | -$58.3M | -$62.1M | -$61.3M | |
Depreciation & Amoritzation | $674K | $1.3M | $1.7M | $2.3M | $3M | |
Stock-Based Compensation | $7.9M | $6.3M | $8.9M | $10.3M | $10.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$24.3M | -$39.2M | -$57.6M | -$56.9M | -$55.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$29.2M | -$63M | -$36.7M | $35M | -$58M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $8.8M | $76K | $18.3M | $1.2M | -- | |
Beginning Cash (CF) | $298.7M | $234M | $141.9M | $57.3M | $165M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$44.7M | -$102.1M | -$75.9M | -$20.6M | -$113.8M | |
Ending Cash (CF) | $254M | $131.9M | $65.9M | $36.6M | $51.2M | |
Levered Free Cash Flow | -$24.6M | -$41.2M | -$60.6M | -$58.9M | -$56.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.